Eubiologics designs and deploys engineered microbial consortia that metabolize persistent organic pollutants in soil and groundwater, using genome‑scale modeling and adaptive evolution to achieve high‑rate degradation under site‑specific conditions. The platform integrates in‑situ biosensor strains, GIS‑driven inoculum placement, and cloud‑based analytics to provide real‑time performance monitoring and reduce remediation timelines and costs for contractors, industrial owners, and regulatory agencies.
Funding
Funding not disclosed


Founders
Product
Problem
Persistent organic pollutants (POPs) such as chlorinated solvents, polycyclic aromatic hydrocarbons, and PFAS remain in soil and groundwater for decades, and conventional physicochemical remediation methods are expensive, energy‑intensive, and often generate secondary waste streams.
Solution
Eubiologics applies synthetic microbial ecology to engineer defined consortia that metabolize target contaminants directly in the subsurface. By combining metabolic pathway engineering, genome‑scale modeling, and adaptive laboratory evolution, the consortia achieve high‑rate degradation of a broad spectrum of POPs under variable redox and nutrient conditions. The platform incorporates engineered biosensor strains that emit optical or electrochemical signals, enabling real‑time monitoring of microbial activity and contaminant disappearance. Geospatial dosing algorithms integrate site‑specific hydrogeology data to optimize inoculum placement and minimize ecological disturbance. Eubiologics delivers a turnkey service that includes site characterization, custom consortium design, formulation for soil or aqueous delivery, and post‑deployment performance analytics, thereby reducing remediation timelines and capital costs while meeting regulatory sustainability criteria.
Target Audience
Primary customers are environmental remediation contractors, industrial facilities with legacy contamination, and governmental agencies responsible for brownfield redevelopment and groundwater protection.
Features
- Custom-designed microbial consortia built from genomically characterized strains with engineered catabolic pathways for specific POP classes
- Genome‑scale metabolic modeling and adaptive evolution pipelines that enhance degradation kinetics and stress tolerance
- Formulation technologies (encapsulation, carrier gels, and surfactant‑stabilized suspensions) optimized for soil, groundwater, and slurry applications
- Integrated biosensor strains providing in‑situ optical or electrochemical readouts of contaminant levels and microbial health
- GIS‑driven inoculum placement and dosing software that accounts hydraulic conductivity, contaminant plume geometry, and nutrient gradients
- Cloud‑based analytics dashboard delivering real‑time performance metrics, degradation forecasts, and compliance reporting
- Scalable deployment model from pilot‑scale field trials to full‑site remediation with remote monitoring and adaptive control loops